New York, NY -- (SBWIRE) -- 03/20/2020 -- Dengue is a mosquito-borne viral infection which causes severe flu-like illness and, sometimes cause lethal complications. According to World Health Organization, 'The incidence of dengue has increased 30-fold over the last 50 years. Up to 50-100 million infections are now estimated to occur annually in over 100 endemic countries, putting almost half of the world's population at risk'. Currently, there is only one dengue virus vaccine that is approved. In May 2019, U.S. Food and Drug Administration (FDA), approved Dengvaxia, manufactured by Sanofi Pasteur in United States for use in children 9-16 years. The vaccine can only be given to children and teens who have had one previous laboratory-confirmed case of dengue. Dengvaxia is licensed for use in 19 countries, plus the eligible parts of the European Union and currently available in 10 countries in Latin America and Asia.

Get Access to Sample Pages of "Dengue Vaccine Market" @ https://www.marketindustryreports.com/pdf/220

Major Players Include:

Some of the key players operating in the market include Sanofi, Panacea Biotec Ltd., Biological E, GlaxoSmithKline plc and Takeda Pharmaceutical Company Limited among others.

Market Growth:

The factors playing a pivotal role in driving the market include increasing prevalence of dengue infection globally, favorable government initiatives and increasing research & development activities for the development of dengue vaccine.

To gather deep-rooted insights with respect to market dynamics, competitive landscape and to unlock the market potential of dengue vaccines, subscribe to the report by clicking and filling up the 'Pre-book' section.

To Avail the Offers PRE BOOK Now @ https://www.marketindustryreports.com/prebook-request/220

Research objectives:-

- To study and analyze the global dengue vaccine consumption (value & volume) by key regions/countries, product type and application, history data.
- To understand the structure of the dengue vaccine market by identifying its various sub-segments.
- Focuses on the key global dengue vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.
- To analyze the dengue vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
In the end, dengue vaccineindustry report specifics the major regions, market scenarios with the product price, volume, supply, revenue, production, market growth rate, demand, forecast and so on. This report also presents SWOT analysis, investment feasibility analysis, and investment return analysis.

Get Interesting Discount @ https://www.marketindustryreports.com/discount/220

About Market Industry Reports
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.

We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.

Contact Us:

Phone: + 91 8956767535
Email: sales@marketindustryreports.com